ALAB Q1 2026 Earnings EPS Beat Drives Positive Stock Movement LEGT Q1 2026 Earnings SPAC Reports Positive EPS Amid Ongoing Merger Search IMA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline TKC Q4 2025 Earnings EPS of 440 Amid Modest Stock Decline Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges GPRK Q1 2026 Earnings Strong EPS Performance Amidst Operational Progress